Testing effectiveness (Phase 2)Study completedNCT04111536
What this trial is testing
Developing Oral LT3 Therapy for Heart Failure - HFpEF
Who this might be right for
Heart Failure With Preserved Ejection FractionLow Triiodothyronine Syndrome
University of Pennsylvania 28